blue20tablets_webBig news from the pharmaceutical industry today, as U.S. pharm giant, Merck, plans to buy internationally strong Schering-Plough for $41 billion. This deal comes on the heels of the Pfizer/Wyeth deal, and proves yet again that a patent portfolio must continue to reinvent itself or else drastic actions must be taken. Merck was facing patent expirations on many of its largest profit-making drugs in the next 3-7 years. Schering-Plough apparently doesn’t have the same exposure to patent phase-outs, and its sales are largely from international markets outside of the U.S. There is talk, however, that investors for Schering-Plough will want the price at least another $10 billion higher. We will have to watch and see what happens on that front, but for now, another large pharm company expands its patent roster . . .

This entry was posted on Monday, March 9th, 2009 at 6:28 am.
Categories: Today in IP ~ by Ian McClure.

No Comments, Comment or Ping

Reply to “Facing Patent Expirations, Merck to Buy Schering-Plough”

Warning: Unknown: open(/home/content/55/3688955/tmp/sess_opt3f5vgo62plbu2sbjkr73va1, O_RDWR) failed: No such file or directory (2) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct () in Unknown on line 0